Showing results (81-90 of 3,147) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|May 26, 2019
Galectin-1 inhibition induces cell apoptosis through dual suppression of CXCR4 and Ras pathways in human malignant peripheral nerve sheath tumorsTsung-Chieh Shih, Yunpeng Fan, Sophie Kiss, et al.
Neuro-Oncology|April 23, 2022
Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastomaNoriaki Minami, Donghyun Hong, Nicholas Stevers, et al.
Neuro-Oncology|April 27, 2022
EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastomaJie Ding, Xiaolong Li, Sabbir Khan, et al.
Neuro-Oncology|May 5, 2022
DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patientsFranz L Ricklefs, Richard Drexler, Kathrin Wollmann, et al.
Neuro-Oncology|April 8, 2022
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomesYalan Zhang, Calixto-Hope G Lucas, Jacob S Young, et al.
Neuro-Oncology|January 29, 2022
Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomasCéline Taglang, Georgios Batsios, Joydeep Mukherjee, et al.
Neuro-Oncology|January 29, 2022
Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastasesStephen R Lowe, Christopher P Wang, Amanda Brisco, et al.
Neuro-Oncology|October 21, 2021
The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumorsHideo Nakamura, Hirokazu Takami, Takaaki Yanagisawa, et al.
Neuro-Oncology|March 24, 2022
TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivoShunichiro Miki, Tomoyuki Koga, Andrew M Mckinney, et al.
Neuro-Oncology|February 26, 2022
Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trialsAdriana Fonseca, Cecile Faure-Conter, Matthew J Murray, et al.
Pageof 315